These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
576 related articles for article (PubMed ID: 27090014)
1. Downregulation of HIF-1a sensitizes U251 glioma cells to the temozolomide (TMZ) treatment. Tang JH; Ma ZX; Huang GH; Xu QF; Xiang Y; Li N; Sidlauskas K; Zhang EE; Lv SQ Exp Cell Res; 2016 May; 343(2):148-158. PubMed ID: 27090014 [TBL] [Abstract][Full Text] [Related]
2. GANT61, a GLI inhibitor, sensitizes glioma cells to the temozolomide treatment. Li J; Cai J; Zhao S; Yao K; Sun Y; Li Y; Chen L; Li R; Zhai X; Zhang J; Jiang C J Exp Clin Cancer Res; 2016 Nov; 35(1):184. PubMed ID: 27894350 [TBL] [Abstract][Full Text] [Related]
3. Downregulation of BRCA1-BRCA2-containing complex subunit 3 sensitizes glioma cells to temozolomide. Chai KM; Wang CY; Liaw HJ; Fang KM; Yang CS; Tzeng SF Oncotarget; 2014 Nov; 5(21):10901-15. PubMed ID: 25337721 [TBL] [Abstract][Full Text] [Related]
4. Bortezomib inhibits growth and sensitizes glioma to temozolomide (TMZ) via down-regulating the FOXM1-Survivin axis. Tang JH; Yang L; Chen JX; Li QR; Zhu LR; Xu QF; Huang GH; Zhang ZX; Xiang Y; Du L; Zhou Z; Lv SQ Cancer Commun (Lond); 2019 Dec; 39(1):81. PubMed ID: 31796105 [TBL] [Abstract][Full Text] [Related]
5. FBW7 is associated with prognosis, inhibits malignancies and enhances temozolomide sensitivity in glioblastoma cells. Lin J; Ji A; Qiu G; Feng H; Li J; Li S; Zou Y; Cui Y; Song C; He H; Lu Y Cancer Sci; 2018 Apr; 109(4):1001-1011. PubMed ID: 29427543 [TBL] [Abstract][Full Text] [Related]
6. BMP2 sensitizes glioblastoma stem-like cells to Temozolomide by affecting HIF-1α stability and MGMT expression. Persano L; Pistollato F; Rampazzo E; Della Puppa A; Abbadi S; Frasson C; Volpin F; Indraccolo S; Scienza R; Basso G Cell Death Dis; 2012 Oct; 3(10):e412. PubMed ID: 23076220 [TBL] [Abstract][Full Text] [Related]
7. Down-Regulation of AQP4 Expression via p38 MAPK Signaling in Temozolomide-Induced Glioma Cells Growth Inhibition and Invasion Impairment. Chen Y; Gao F; Jiang R; Liu H; Hou J; Yi Y; Kang L; Liu X; Li Y; Yang M J Cell Biochem; 2017 Dec; 118(12):4905-4913. PubMed ID: 28569417 [TBL] [Abstract][Full Text] [Related]
8. DNMT1 mediates chemosensitivity by reducing methylation of miRNA-20a promoter in glioma cells. Zhou D; Wan Y; Xie D; Wang Y; Wei J; Yan Q; Lu P; Mo L; Xie J; Yang S; Qi X Exp Mol Med; 2015 Sep; 47(9):e182. PubMed ID: 26337869 [TBL] [Abstract][Full Text] [Related]
9. Resveratrol restores sensitivity of glioma cells to temozolamide through inhibiting the activation of Wnt signaling pathway. Yang HC; Wang JY; Bu XY; Yang B; Wang BQ; Hu S; Yan ZY; Gao YS; Han SY; Qu MQ J Cell Physiol; 2019 May; 234(5):6783-6800. PubMed ID: 30317578 [TBL] [Abstract][Full Text] [Related]
10. Downregulation of ROCK2 through nanocomplex sensitizes the cytotoxic effect of temozolomide in U251 glioma cells. Wen X; Huang A; Liu Z; Liu Y; Hu J; Liu J; Shuai X PLoS One; 2014; 9(3):e92050. PubMed ID: 24642531 [TBL] [Abstract][Full Text] [Related]
11. Oroxylin A increases the sensitivity of temozolomide on glioma cells by hypoxia-inducible factor 1α/hedgehog pathway under hypoxia. Wei M; Ma R; Huang S; Liao Y; Ding Y; Li Z; Guo Q; Tan R; Zhang L; Zhao L J Cell Physiol; 2019 Aug; 234(10):17392-17404. PubMed ID: 30790292 [TBL] [Abstract][Full Text] [Related]
12. Apoptosis in malignant glioma cells triggered by the temozolomide-induced DNA lesion O6-methylguanine. Roos WP; Batista LF; Naumann SC; Wick W; Weller M; Menck CF; Kaina B Oncogene; 2007 Jan; 26(2):186-97. PubMed ID: 16819506 [TBL] [Abstract][Full Text] [Related]
13. Differential Characterization of Temozolomide-Resistant Human Glioma Cells. Lai SW; Huang BR; Liu YS; Lin HY; Chen CC; Tsai CF; Lu DY; Lin C Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29301329 [TBL] [Abstract][Full Text] [Related]
14. Chemoresistance to temozolomide in human glioma cell line U251 is associated with increased activity of O6-methylguanine-DNA methyltransferase and can be overcome by metronomic temozolomide regimen. Pan Q; Yang XJ; Wang HM; Dong XT; Wang W; Li Y; Li JM Cell Biochem Biophys; 2012 Jan; 62(1):185-91. PubMed ID: 21892781 [TBL] [Abstract][Full Text] [Related]
15. Knockdown of RLIP76 expression by RNA interference inhibits invasion, induces cell cycle arrest, and increases chemosensitivity to the anticancer drug temozolomide in glioma cells. Wang Q; Qian J; Wang J; Luo C; Chen J; Hu G; Lu Y J Neurooncol; 2013 Mar; 112(1):73-82. PubMed ID: 23292182 [TBL] [Abstract][Full Text] [Related]
16. Downregulation of hsa_circ_0000936 sensitizes resistant glioma cells to temozolomide by sponging miR-1294. Hua L; Huang L; Zhang X; Feng H J Biosci; 2020; 45():. PubMed ID: 32975228 [TBL] [Abstract][Full Text] [Related]
17. Silencing hypoxia-inducible factor-1alpha inhibits cell migration and invasion under hypoxic environment in malignant gliomas. Fujiwara S; Nakagawa K; Harada H; Nagato S; Furukawa K; Teraoka M; Seno T; Oka K; Iwata S; Ohnishi T Int J Oncol; 2007 Apr; 30(4):793-802. PubMed ID: 17332917 [TBL] [Abstract][Full Text] [Related]
18. Knockdown of Nrf2 enhances autophagy induced by temozolomide in U251 human glioma cell line. Zhou Y; Wang HD; Zhu L; Cong ZX; Li N; Ji XJ; Pan H; Wang JW; Li WC Oncol Rep; 2013 Jan; 29(1):394-400. PubMed ID: 23128449 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of DNA-repair genes Ercc1 and Mgmt enhances temozolomide efficacy in gliomas treatment: a pre-clinical study. Boccard SG; Marand SV; Geraci S; Pycroft L; Berger FR; Pelletier LA Oncotarget; 2015 Oct; 6(30):29456-68. PubMed ID: 26336131 [TBL] [Abstract][Full Text] [Related]
20. Upregulation of CASC2 sensitized glioma to temozolomide cytotoxicity through autophagy inhibition by sponging miR-193a-5p and regulating mTOR expression. Jiang C; Shen F; Du J; Fang X; Li X; Su J; Wang X; Huang X; Liu Z Biomed Pharmacother; 2018 Jan; 97():844-850. PubMed ID: 29136760 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]